143 related articles for article (PubMed ID: 2314008)
1. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.
Creutzig A; Caspary L; Alexander K
Klin Wochenschr; 1990 Feb; 68(4):207-12. PubMed ID: 2314008
[TBL] [Abstract][Full Text] [Related]
2. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
Thum J; Caspary L; Creutzig A; Alexander K
Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
[TBL] [Abstract][Full Text] [Related]
4. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
5. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
[TBL] [Abstract][Full Text] [Related]
6. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
Fagrell B; Lundberg G; Olsson A; Ostergren J
Vasa; 1986; 15(1):56-60. PubMed ID: 3962459
[No Abstract] [Full Text] [Related]
7. Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive disease.
Creutzig A; Caspary L; Alexander K
Int J Microcirc Clin Exp; 1991 Aug; 10(3):231-40. PubMed ID: 1955281
[TBL] [Abstract][Full Text] [Related]
8. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
9. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
Heidrich H; Brodel C; Meuche C; Hellmann G; Ranft J
Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
[No Abstract] [Full Text] [Related]
10. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
Thum J; Caspary L; Creutzig A; Alexander K
Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
[No Abstract] [Full Text] [Related]
11. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
Creutzig A; Creutzig H; Alexander K
Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
[TBL] [Abstract][Full Text] [Related]
12. Conservative treatment of inoperable arterial occlusions of the lower extremities with intra-arterial prostaglandin E1.
Gruss JD; Bartels D; Ohta T; Machado JL; Schlechtweg B
Br J Surg; 1982 Jun; 69 Suppl():S11-3. PubMed ID: 7044465
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.
Hirai M; Nakayama R
Br J Surg; 1986 Jan; 73(1):20-3. PubMed ID: 3947867
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
Weiss T
Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
16. [The reproducibility of transcutaneous oxygen pressure by continuous registration].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():32-3. PubMed ID: 1481053
[No Abstract] [Full Text] [Related]
17. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
[No Abstract] [Full Text] [Related]
18. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
[TBL] [Abstract][Full Text] [Related]
19. Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation.
Caspary L; Creutzig A; Alexander K
Eur J Clin Pharmacol; 1991; 41(2):131-6. PubMed ID: 1720738
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
